Aim. Polycystic ovary syndrome (PCOS) is one of the most common causes of ovulatory infertility. It is an endocrine disorders characterized by a high level of male hormones (androgens) and frequent anovulatory cycles associated with multiple ovarian microcysts. The aim of this paper was to evaluate effects of a Clomiphene citrate alone versus a combined treatment (Metformin and Clomiphene citrate). Methods. A total of 60 women with PCOS and infertility were evaluated. Inclusions criteria were: age 26-34 years, nulliparity, above 3 years of sterility, multiple ovarian microcysts, BMI>27.5, oligomenorrhea/amenorrhea, hyperandrogenism and normal male fertility. Four patients were excluded (renal damage 2, tubal occlusion 1 and Pelvic Inflammatory Disease 1). The remaining 56 were divided into 2 groups: group A were inducted with Clomiphene Citrate alone, while group B were inducted with Clomiphene citrate and Metformin. Results. In group A we obtained ovulation in 20 women (71.4%), 8 pregnancies (28.5%) and one (3.5%) spontaneous abortion. In group B we obtained ovulation in 24 women (85.7%), 15 pregnancies (53.5%) and no spontaneous abortions. Conclusion. Combined treatment was found to be more effective (53.5) in improving pregnancy rate compared to monotherapy (28.5%).
|Titolo:||Ovulation induction with clomiphene citrate and metformin in women with polycystic ovary syndrome|
|Data di pubblicazione:||2014|
|Citazione:||Ovulation induction with clomiphene citrate and metformin in women with polycystic ovary syndrome / Leanza V; Coco L; Grasso F; Leanza G; Zarbo G; Palumbo M. - 66:3(2014), pp. 00264784.299-00264784.301.|
|Appare nelle tipologie:||1.1 Articolo in rivista|